A team of researchers at the University of California, Los Angeles (UCLA) has introduced a novel framework for monitoring ...

BioNTech and partner DualityBio are accelerating the development of their B7-H3 antibody-drug conjugate into a phase 3 trial for metastatic castration-resistant prostate cancer (mCRPC). | BioNTech and ...

BioNTech has sued Moderna, alleging its mNEXSPIKE vaccine uses patented COVID vaccine technology without authorization.

Feb 19 (Reuters) - German biopharmaceutical company BioNTech sued Moderna in Delaware federal court on Thursday, alleging that Moderna's ‌COVID-19 shot mNEXSPIKE infringes a patent related to COVID ...

Feb 19 (Reuters) - German biopharmaceutical company BioNTech (22UAy.DE), opens new tab sued Moderna (MRNA.O), opens new tab in Delaware federal court on Thursday, alleging that Moderna's COVID-19 shot ...

BioNTech SE is flexible about its future structure as it prepares to bring a slew of cancer drugs to market, with its chief executive officer saying he would consider a deal with a partner that gets ...

Scientists in South Korea have discovered a way to make all-solid-state batteries safer and more powerful using inexpensive materials. Instead of adding costly metals, they redesigned the battery’s ...

An update from BioNTech SE ( (BNTX)) is now available. On January 6, 2026, BioNTech SE reported that CureVac N.V. had completed a previously announced post-offer reorganization related to BioNTech’s ...

Add Yahoo as a preferred source to see more of our stories on Google. The logo of BioNTech is pictured at Biontech's research laboratory for individualised vaccines against cancer in Mainz, Germany, ...

BioNTech SE raised its sales forecast for the year, helped by a boost from its partnership with Bristol-Myers Squibb Co. The German biotech now expects revenue as high as €2.8 billion ($3.2 billion) ...

MAINZ, Germany, October 28, 2025 (GLOBE NEWSWIRE)-- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”), will host an edition of the Company’s Innovation Series R&D Day at 09:00 a.m. Eastern ...

The cancer drug BioNTech is developing with a China-based peer did well in a late-stage, head-to-head trial. The drug met its primary endpoint in the study. BioNTech and Chinese peer Duality Biologics ...